Log In
Print this Print this

elsiglutide (ZP1846)

  Manage Alerts
Collapse Summary General Information
Company Zealand Pharma A/S
DescriptionGlucagon-like peptide-2 receptor (GLP-2R) analog
Molecular Target Glucagon-like peptide-2 receptor (GLP-2R)
Mechanism of ActionGlucagon-like peptide-2 (GLP-2) receptor agonist
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPhase II
Standard IndicationDiarrhea (non-infectious)
Indication DetailsPrevent chemotherapy-induced diarrhea; Treat severe chemotherapy-induced diarrhea
Regulatory Designation
PartnerHelsinn Healthcare S.A.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today